-
Product Insights
NewNet Present Value Model: Monopar Therapeutics Inc’s Camsirubicin
Empower your strategies with our Net Present Value Model: Monopar Therapeutics Inc's Camsirubicin report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Positron Emitting Tomography Contrast Agents ·       Magnetic Resonance Imaging (MRI) Contrast Agents ·       Gadolinium-based MRI Contrast Agents...
-
Product Insights
NewNet Present Value Model: Novo Nordisk AS’s NNC-03653769A
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3532226 in Type 1 Diabetes (Juvenile Diabetes)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. LY-3532226 in Type 1 Diabetes (Juvenile Diabetes) Drug Details: LY-3532226 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Camsirubicin in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Camsirubicin in Soft Tissue Sarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Camsirubicin in Soft Tissue Sarcoma Drug Details:camsirubicin is under development for the...
-
Company Profile
Monopar Therapeutics Inc – Company Profile
Monopar Therapeutics Inc (Monopar) is a clinical-stage biopharmaceutical company. The company’s pipeline products include validive, for chemoradiation-induced SOM; camsirubicin, to treat advanced soft tissue sarcoma; MNPR-101 RIT, to treat advanced solid cancers; MNPR-101ZR, to treat solid cancers; MNPR-202, to treat advanced solid cancers and others. The company’s lead drug product candidate enters clinical development through collaboration with research center in the UK. It also carries out various phases of clinical trials. The company’s brands include Validive. Monopar is headquartered in...
Add to Basket -
Product Insights
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ovarian Cancer Pipeline Products Market Report Overview Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, and changes in bowel habits, such as constipation, loss of appetite, and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy, and radiation...
-
Product Insights
Net Present Value Model: Validive
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Validive Drug Details Clonidine ER (Validive,...
-
Product Insights
Net Present Value Model: Camsirubicin
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Camsirubicin Drug Details camsirubicin is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – clonidine ER
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry clonidine ER Drug Details Clonidine ER is under development for the treatment of sciatic...